Evolutionary biology of cancer

Jerry D Glickson

Mechanism of Activity of Lonidamine

Melanoma of skin

Pathology

Ann Ager

Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity

Melanoma of skin All cancers but non-melanoma skin cancer

Pathology

Eduardo M. Sotomayor

Regulation of Cross-Tolerance to Tumor Antigens

Melanoma of skin All cancers but non-melanoma skin cancer

Shine Chang

Cancer Prevention Education: Student Research Experiences

Melanoma of skin All cancers but non-melanoma skin cancer

Alan Fersht

Structural biology of the tumour suppressor p53 and its complexes

Melanoma of skin All cancers but non-melanoma skin cancer

Marcel Bally

Lipid-based nanopharmaceuticals alone and in combination to treat aggressive forms of cancer: Design and development of formulations capable of causing tumor specific blood vessel damage

Melanoma of skin All cancers but non-melanoma skin cancer

Magali Olivier

Modeling mutational landscapes of primary cancers using an in vitro cell immortalization assay

Melanoma of skin All cancers but non-melanoma skin cancer

Elena Vigorito

MiRNA-155 regulates B cell function through its target PU.1

Melanoma of skin All cancers but non-melanoma skin cancer

Amy R. Howell

Harnessing NKT Cell Activation by Glycolipids

Melanoma of skin All cancers but non-melanoma skin cancer